Serum Institute intends to launch development of covid-19 vaccines in May 2020

Serum Institute of India is a manufacturer of immunobiological drugs including Indian vaccines. It was established in 1966 by the Cyrus Poonawalla. The firm is the largest manufacturer of vaccines in the world by number of doses produced. Currently it is developing a swine flu vaccine intra-nasal.


The Serum Institute of India is rated as the No. 1 biotechnology firm in India, developing extremely advanced life-saving biologics such as vaccinations utilizing cutting-edge genomic and cell-based techniques, antisera and other medical specialties.

The Serum Institute of India, which is collaborating with Oxford University for a successful covid-19 under-trial vaccine, aims to get the vials ready for use by September-October, its chief executive said on Tuesday as US scientists announced progress with the Oxford animal vaccine.Tuesday brought in unprecedented positive news against the devastating covid-19 pandemic in the world war.


Scientists at the Rugged Mountain Laboratories in Hamilton, USA, announced that six rhesus monkeys were "safe" 28 days later inoculated with the Oxford University vaccine and then subjected to large quantities of the novel coronavirus, the New York Times announced.The Serum Institute, the biggest vaccine producer in the country, is a marketing affiliate of the Oxford University project, one of seven such collaborators across the globe.A team headed by Professor Adrian Hill, head of the Oxford-based Jenner Institute, also launched clinical testing of the vaccine on 23 April. To be sure, progress with animal research doesn't automatically mean that human testing would also be effective.


The vaccine candidate named ChAdOx1 nCoV-19 is created from a virus (ChAdOx1), a modified variant of a common cold virus (adenovirus) that triggers chimpanzee infection. Genetically engineered the virus to insure it can't spread in humans.
The vaccination has been offered to more than 320 people so far, and has been proven to be effective and well-tolerated, while it may induce acute side effects such as fever, cough, or sore shoulder, Oxford University said. About 1,110 participants will enroll in the experiment, half will receive the vaccine and half (the control group) will receive a readily accessible meningitis vaccine.
Erum Institute of India Chief Executive Officer Adar Poonawalla said in an interview on Tuesday: "Although clinical trials have already begun in the United Kingdom, we are also beginning development simultaneously, hoping that the first batch of doses will be ready for use by September or October when the trials are successful."

Serum Institute of India Vaccine & Immunobiologics Serum Institute intends to launch development of covid-19 vaccines in May

Website design company in kolkata